Identification of Potential RBPJ-Specific Inhibitors for Blocking Notch Signaling in Breast Cancer Using a Drug Repurposing Strategy
Notch signaling is a key parameter in regulating cell fate during tissue homeostasis, and an aberrant Notch pathway can result in mammary gland carcinoma and has been associated with poor breast cancer diagnosis. Although inhibiting Notch signaling would be advantageous in the treatment of breast ca...
Saved in:
Main Authors: | Mengjie Rui (Author), Min Cai (Author), Yu Zhou (Author), Wen Zhang (Author), Lianglai Gao (Author), Ke Mi (Author), Wei Ji (Author), Dan Wang (Author), Chunlai Feng (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Oridonin inhibits breast cancer growth and metastasis through blocking the Notch signaling
by: Shixin Xia, et al.
Published: (2017) -
Notch signalling and proneural genes work together to control the neural building blocks for the initial scaffold in the hypothalamus
by: Michelle eWare, et al.
Published: (2014) -
Notch Signaling Pathway and Endocrine Resistance in Breast Cancer
by: Jing-Wen Bai, et al.
Published: (2020) -
Mutations Status of NOTCH Signaling Pathway Predict Prognosis of Immune Checkpoint Inhibitors in Colorectal Cancer
by: Lin A, et al.
Published: (2023) -
Repurposing existing drugs: identification of irreversible IMPDH inhibitors by high-throughput screening
by: Albertus Eka Yudistira Sarwono, et al.
Published: (2019)